Propanc Biopharma, Inc. (PPCB)
PPCB Stock Price Chart
Explore Propanc Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze PPCB price movements and trends.
PPCB Company Profile
Discover essential business fundamentals and corporate details for Propanc Biopharma, Inc. (PPCB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Nov 2012
Employees
1.00
Website
https://www.propanc.comCEO
James Nathanielsz
Description
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
PPCB Financial Timeline
Browse a chronological timeline of Propanc Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Sept 2025
Earnings released on 15 May 2025
EPS came in at -$12.50 .
Earnings released on 14 Feb 2025
EPS came in at -$32.23 .
Stock split effective on 29 Jan 2025
Shares were split 1 : 60000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$287.82 .
Earnings released on 30 Sept 2024
EPS came in at -$253.05 .
Earnings released on 15 May 2024
EPS came in at -$625.00 .
Earnings released on 20 Feb 2024
EPS came in at -$1.88K .
Earnings released on 14 Nov 2023
EPS came in at -$2.50K .
Earnings released on 28 Sept 2023
EPS came in at -$0.12 .
Stock split effective on 23 May 2023
Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$0.42 .
Earnings released on 9 Feb 2023
EPS came in at -$0.51 .
Earnings released on 14 Nov 2022
EPS came in at -$1.30 .
Earnings released on 28 Sept 2022
EPS came in at -$4.11 .
Earnings released on 16 May 2022
EPS came in at -$625.00K .
Earnings released on 14 Feb 2022
EPS came in at -$1.25M .
Earnings released on 12 Nov 2021
EPS came in at -$1.25M .
Earnings released on 28 Sept 2021
EPS came in at -$55.43 .
Earnings released on 14 May 2021
EPS came in at -$7.50M .
Earnings released on 12 Feb 2021
EPS came in at -$28.13M .
Stock split effective on 19 Nov 2020
Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Nov 2020
EPS came in at -$712.43 .
Earnings released on 1 Oct 2020
EPS came in at $4.66K .
PPCB Stock Performance
Access detailed PPCB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.